Key result
Preoperative statin use is linked to an absolute ~1.6% lower in-hospital risk in aortic valve surgery.
Why the study?
Whether preoperative statins improve outcomes in cardiac surgery remains uncertain, arguing against uniform use and motivating patient-specific risk-benefit assessment among patients undergoing aortic valve surgery.
Does preoperative statin use within 24 hours of surgery reduce the composite in-hospital outcome in adults undergoing aortic valve surgery?
Cohort (n=1,067)
No
Does preoperative statin use within 24 hours of surgery reduce the composite in-hospital outcome in adults undergoing aortic valve surgery?
In a single-center cohort of patients undergoing aortic valve surgery, deep learning causal inference modeling showed that preoperative statin use was associated with a 1.56 percentage point lower risk of the in-hospital composite outcome.
Answers are grounded in this paper and cite their sources.
Individualized statin decisions before aortic valve surgery require validation; leaves open causal effects for randomized confirmation.
Objective Whether preoperative statins improve outcomes in cardiac surgery remains uncertain, arguing against uniform use and motivating patient-specific risk–benefit assessment. We evaluated patient-level heterogeneity in the modeled association between documented preoperative statin use and outcomes among patients undergoing aortic valve surgery. Methods We assembled a retrospective cohort of consecutive adults who underwent aortic valve surgery. Exposure was documented statin use within 24 hours before surgery. The preoperative-covariate model was designated the primary specification for the composite in-hospital outcome; the full perioperative model was secondary. Treatment overlap and characteristics of patients excluded for missing baseline data were assessed. Five-year mortality was examined descriptively with explicit accounting for incomplete follow-up. Results A total of 1,067 patients were analyzed, of whom 340 (31.9%) had documented preoperative statin use. The primary preoperative-covariate model estimated composite risks of 6.009% without statin and 4.449% with statin, corresponding to a risk difference of −1.560 percentage points (nominal 95% interval, −2.525 to −0.699). The secondary full perioperative estimate was −1.22 percentage points (95% CI, −2.22 to −0.26). Observed-range propensity-score common support included 97.8% of patients, although 15.0% had scores below 0.05 or above 0.95. Conclusions In this single-center cohort, documented preoperative statin use was associated with a lower model-estimated in-hospital composite risk in the preoperative-covariate analysis. These observational findings require external validation before clinical application.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2026) conducted a cohort in Aortic valve surgery (n=1,067). Documented preoperative statin use within 24 hours before surgery vs. No preoperative statin use was evaluated on Composite in-hospital outcome (Risk difference -1.560 percentage points, 95% CI -2.525 to -0.699). Preoperative statin use was associated with a lower model-estimated in-hospital composite risk in aortic valve surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: